Skip to main content

Table 1 Clinical data of HCM and DCM patients

From: MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM

 

HCM

DCM

p

Sample number

10

10

 

Mean age (years)

39 ± 14

47 ± 14

0.23

Male sex (%)

80%

80%

1

BMI (kg/m2)

22 ± 4.31

20 ± 1.51

0.26

UCG

   

 LVEF (%)

30.29 ± 10.42

25 ± 6.37

0.21

 LVEDD (mm)

61.6 ± 14.04

68.6 ± 7.98

0.21

 IVS (mm)

13.98 ± 3.16

8.9 ± 1.36

0.001**

 LVPW (mm)

10.48 ± 3.33

8.6 ± 1.28

0.141

Comorbidities

 Hypertension

20% (2)

0

0.151

 Ventricular tachycardia

40% (4)

40% (4)

1

 Diabetes

10% (1)

50% (5)

0.054

 Myocardial infarction

0

0

1

 Atrial fibrillation

40% (4)

50% (5)

0.673

Medications

   

 Digoxin

50% (5)

70% (7)

0.388

 β-blocker

80% (8)

40% (4)

0.074

 Aldosterone antagonist

70% (7)

50% (5)

0.388

 ACE inhibitor/ARB

20% (2)

20% (2)

1

Mean heart weight (g)

542.1 ± 144.88

380.9 ± 61.01

0.01*

  1. Data are expressed as mean ± SD
  2. BMI body mass index; UCG ultrasound cardiogram; LVEF left ventricular ejection fraction; LVEDD left ventricular end diastolic diameter; IVS interventricular septum; LVPW left ventricular posterior wall; ARB Angiotension receptor blocker
  3. *p < 0.05, **p < 0.01, ***p < 0.001